Novo Nordisk A/S Price Today
Novo Nordisk A/S
NVO
Healthcare
$568.72B
💰
Market Cap
47.2
💸
Price to Earnings
$2.7
🎉
EPS
+0
🌳
ESG
Consensus Recommendations
Buy Consensus
Buy |
14 |
Strong Buy |
6 |
Hold |
10 |
Sell |
0 |
Strong Sell |
1 |
NVO Price Forecast Target
127.5 👉 160.0 +26%
NVO EPS Forecast
2.7 👉 4.0 +47%
Financials
Profit Margin
36 %
Revenue Growth
37.0 %
Dividend
$ 1.37
Held Percent
0.0% - Insiders
9.3% - Institutions
90.7% - Public
Major Fund Holders
-
💰 $
-
💰 $
-
💰 $
-
💰 $
-
💰 $
Stock Ideas
Nancy Pelosi Portfolio
Nancy Pelosi is the Speaker of the United States House of Representatives and a savvy investor. Her personal portfolio is heavily weighted towards large-cap tech stocks, such as Apple and Microsoft. She also owns shares in several consumer staples a…
David Shaw Portfolio
David Shaw is a renowned computer scientist, technological pioneer, and founder of D.E. Shaw Group, one of the earliest quantitative hedge funds. Shaw pioneered the use of algorithmic and computational modeling in institutional investing. While litt…
George Soros Portfolio
George Soros is a legendary hedge fund manager who made history when he earned 1 billion in 1992 and became known as 'the Man Who Broke the Bank of England'. "With an estimated net worth of 14.2 billion, Soros is ranked 35th on the list of the world…
Howard Marks Portfolio
Meet Howard Marks, the co-founder and lead of Oaktree Capital Management, a Los Angeles-based investment firm that manages roughly $78 billion in investment capital. Marks has an impressive background in distressed debt, high yield bonds, and conver…📮FAQ
Some Frequently Asked Questions.
The Novo Nordisk A/S industry is Biotechnology
The Novo Nordisk A/S sector is Healthcare
The Novo Nordisk A/S forecasted predicted Price to Earnings PE ratio is 32.1
The Novo Nordisk A/S Price to Earnings PE ratio is 47.2
The Market Capitalization of Novo Nordisk A/S is $568.72B
There are total of 3192981244 float shares with 9.3% held by Institutions and 0.0% held by insiders
The MNovo Nordisk A/S forecasted Earnings per Share EPS is $4.0
The Novo Nordisk A/S Earnings per Share EPS is 2.7
The Novo Nordisk A/S company has $0 gross profits with 36 profit margins
The Novo Nordisk A/S Earnings Growth is 0.631% with 0.616% quarterly earnings growth
The Novo Nordisk A/S Revenue is $232260993024 with 0.37 revenue growth
The price target for Novo Nordisk A/S stock is $160.0 for the high target and $130.0 for the low target
The consensus analyst recommendations for Novo Nordisk A/S is Buy, however the decision to buy or sell the stock should be entirely yours, as you are earning your own money and hence responsible on how to allocate and spend them.
The consensus analyst recommendations for Novo Nordisk A/S is Buy, with the following breakdown:
- Buy: 14
- Strong Buy: 6
- Hold: 10
- Sell: 0
- Strong Sell: 1
The Beta of Novo Nordisk A/S is 0.2
The dividend of Novo Nordisk A/S is $1.37
The dividend yield of Novo Nordisk A/S is 0.0108%
The biggest institutional and mutual fund holders of Novo Nordisk A/S stock are
The Novo Nordisk A/S ESG Score is 0, with the following breakdown:
- E: 0
- S: 0
- G: 0